New Delhi: British drugmaker AstraZeneca admitted covid vaccines could cause blood clots but said these were “extremely rare” after more than 50 such cases were reported in the UK in patients administered jabs that had been made by the Serum Institute of India. The company said on Tuesday that patient safety is its highest priority. Regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines, it added.The pharma company said regulators... Read this story at mint , mint , mint , Food & Wine , mint , mint , mint , mint , mint , mint , mint , mint
